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ABSTRACT 
Case Background and Purpose. Parkinson’s disease (PD) is a progressive neurological 
pathology which leads to a decrease in functional capabilities. Non-pharmacologic treatment 
programs do exist which can enable people to function better while living with this disease. The 
purpose of this study was to assess the effect of the LSVT BIG™ exercise protocol on measures 
of balance, gait, and cardiovascular fitness in two subjects with PD. 
Case Description. The case study was an A-B design. Two individuals with PD consented to 
perform the outcome measures weekly for four weeks followed by four weeks of the LSVT 
BIG™ treatment protocol plus weekly testing. The outcome measures included Multi-directional 
Reach Test (MDRT), the GAITRite™ gait analysis system, electromyography (EMG), postural 
stability and limits of stability tests on Biodex™ Balance SD (BBSD), Functional Gait 
Assessment (FGA), Brief Balance Evaluation Systems Test (Brief BESTest), Five Times Sit to 
Stand (FTSTS), Six Minute Walk Test (6MWT), heart rate, blood pressure, and pulse oximetry. 
Outcome. The two participants demonstrated significant benefits in the outcome measures used. 
However, the number of changed measures for each subject was not equal, due to differences in 
PD signs.  PD05 was a better candidate as his primary signs were bradykinesia and rigidity. 
Conclusion. Results of this study suggest LSVT BIG™ protocol may be used by patients with 
bradykinesia and rigidity as their primary motor signs of PD to help improve aspects of balance 
and gait.  Further research is needed to solidify the results including more selective sample, 
larger sample size, and monitoring results of outcome measures post intervention period. 






Parkinson’s disease (PD) is a progressive neurological disorder commonly characterized 
by symptoms of bradykinesia, rigidity, resting tremor, and postural instability. The cause of this 
disorder is not well understood but it is speculated to occur due to both genetic and 
environmental factors1. Despite not knowing the initiating factor, the pathogenesis has been 
observed to be a slow degeneration of dopamine-producing neurons in the substantia nigra pars 
compacta, located in the basal ganglia. Considering the nuclei of the basal ganglia are involved 
with regulation of motor function and require dopamine to function normally, loss of these 
dopaminergic neurons ultimately leads to the movement dysfunction found in people with PD2,3. 
There is no cure for PD, therefore treatment is directed in terms of symptomatic relief4. 
Medical management of PD usually involves the administration of levodopa due to the drug’s 
ability to raise dopamine levels and dramatically reduce PD symptoms3. Despite the benefits, 
levodopa may also result in adverse side effects such as nausea, vomiting, cardiac arrhythmias, 
dyskinesias, and possible behavioral changes2. Also, one of the bigger issues with prolonged use 
of levodopa is decreased effectiveness over a period of years2. Other pharmacological options to 
manage PD do exist, but like levodopa, these drugs may come with serious side-effects. 
Due to the side effects of pharmacologic agents, it is important to also explore non-
pharmacologic treatments. Multiple activity-based treatments exist that have demonstrated 
significant improvement in different factors for people with PD5,6,7 but still there is no conclusive 
research stating one treatment is more effective than another. The purpose of this literature 
review is to examine different treatment techniques to determine how those treatments relate to 
the possible success of using the LSVT BIG™ protocol as an option for people with PD. 
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Hackney and Earhart hypothesize that Argentine tango incorporates actions which 
specifically target PD-related impairments such as initiation of movement, weight shifting, 
taking steps in different directions, and making turns. Subjects participated in one-hour dance 
classes twice a week for twenty sessions. The subjects in the dance group show significant 
improvements in the Berg Balance Scale (BBS), Six-Minute Walk Test (6MWT), and backward 
stride length8, suggesting Argentine tango may be a successful rehabilitation technique. 
Tai Chi movements are mind-body exercises that incorporate a number of whole-body 
postures which are linked together in a continuous sequence. These movements emphasize 
weight shifts and slow, controlled movements of upper and lower extremities9. A systematic 
review examines ten articles to determine the effect Tai Chi has on PD subjects in terms of 
balance, mobility, functional reach, quality of life, gait quality, and fall risk10. Yan et al report a 
significant improvement in balance and mobility scoring of subjects with PD Tai Chi 
participation10. The researchers conclude that, because it involves joint control and muscle 
coordination, Tai Chi helps people with PD by promoting postural stability and balance10. 
Other studies have looked into the effect high-intensity exercises have on subjects with 
PD.  Fifteen subjects underwent a sixteen week high-intensity resistance training program, 
performing exercises while maintaining a heart rate above 50% of their heart rate reserve. The 
subjects made improvements in strength, balance, neuromuscular control, and cardiorespiratory 
fitness11. In a different study, twelve subjects went through a personalized high intensity exercise 
program consisting of resistance, cardiovascular, balance, and flexibility training12. Results 
demonstrate significant improvements in activities of daily living, motor performance, and 
mentation for the subjects in the intervention group12. Morberg et al hypothesize one-on-one 
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training enables subjects to focus intensely on the exercises being performed due to guidance and 
cueing, allowing each subject to receive the maximum benefit of the exercise regimen12. 
Research suggests a treatment in high amplitude movements might be effective for 
people with PD.  Berardelli et al. proposed bradykinesia is due to lack of recruitment of force 
during muscle activation, resulting in underscaling of movements13. This causes a need to 
perform multiple attempts to achieve targeted movement13. Bradykinesia may be improved upon 
by amplitude-specific training. Farley and Koshland hypothesize amplitude-specific movements 
of functional tasks target the pathological mechanisms that underlie bradykinesia in PD by 
promoting activation of basal ganglia pathways and slowing their decline14. Their study observes 
the effect of amplitude-based exercise and found this type of training results in an increase in 
speed of upper and lower limb movements. The researchers hypothesize amplitude training 
increased muscle activation which allowed the subjects to meet the force requirements to reach 
target distances with upper and lower limbs14. 
Different factors which made multiple PD treatments successful have been incorporated 
into the LSVT BIG™ protocol, which helps improve limb and trunk movement. The LSVT 
BIG™ program was developed from LSVT LOUD™, an established treatment to improve the 
speech motor system in people with PD14. The treatment principles of LSVT BIG™ are high 
intensity/maximum effort, high amplitude, repetition, and complexity with all movements14. The 
hypothesis behind these principles is that specific exercises will enhance function in targeted 
movements of the subject15. The BIG™ protocol, which includes part standardized exercises and 
part personalized exercises, is delivered by trained clinicians in one-on-one treatment sessions to 
ensure exercises are performed safely and properly. 
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The purpose of this study was to investigate the impact of the LSVT BIG™ protocol on 
two subjects with PD. The outcome measures were used to determine changes in balance, gait 
quality, and the cardiovascular system. The measures included the Five-Time Sit-to-Stand, Brief 
BESTest, Biodex™ balance testing, Multidirectional Reach Test, Functional Gait Assessment, 
electromyography, Six-Minute Walk Test, and vital signs. 
METHODS 
Participants 
Approval was received through the Internal Review Board committee of Angelo State 
University. Volunteers were recruited at the local PD support group, where the researchers 
presented an overview of the project and welcomed interested members to participate. Two 
volunteers committed to the two-month research study and provided informed consent (Table 1). 
PD04 was an 81 year-old female with a 3.5 year history of diagnosed PD, with initial symptoms 
beginning approximately 20 years prior to the study. Participant PD04 was not an ideal match for 
the BIG protocol, as it was designed to address bradykinesia and rigidity while her primary PD 
sign was tremors. PD04 had the added caution of a history of surgically corrected cardiac valve. 
PD05 was a 63 year-old male with a 0.5 year history of diagnosed PD, with symptoms beginning 
approximately 1.0 years prior. Primary PD signs included bradykinesia and cogwheel rigidity, 
while mild extremity tremors and other secondary symptoms were also present. PD05 also 
reported cardiac issues of 10% arterial blockage and occasional palpitations with exertion. 
Cardiovascular objective measures as well as subjective symptom reports from both subjects 
were monitored throughout the program to ensure subject safety. Both subjects met the inclusion 
criteria of no fractures or orthopedic surgeries in past year, no history of stroke, and the ability to 
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understand and follow instructions, ability to walk independently 30 meters with or without an 
assistive device such as a cane or walker. Exclusion criteria included:  deep brain stimulators, 
severe cardiac or respiratory issues that may limit participation in an exercise protocol, and 
cognitive impairments that prevent being able to follow commands.    
Research Design 
The single-subject A-B design study followed two subjects through baseline and 
intervention phases over the course of two months to assess effectiveness of the LSVT BIG™ 
exercise protocol on clinical measures of balance, gait, and cardiovascular system in participants 
with PD.  
Outcome Measures 
Participants were assessed at 8 time points: weekly baseline measure for 4 weeks prior to 
the initiation of intervention and weekly measures during the 4 weeks of intervention.  Full 
outcome measure instructions are located in Appendix A. 
Five Times Sit-To-Stand. Sit-to-stand is a key functional indicator of balance, more closely tied 
to the Berg Balance Scale than are muscle strength or exercise endurance via 6MWT.16  For the 
Parkinson’s population, a completion time greater than 16 seconds indicates fall risk.17  As 
further discussed in the Instrumented Sit-to-stand section below, the activity of transferring from 
sit-to-stand is composed of four distinct kinematic phases requiring vastly different motor 
recruitment and momentum-transfer strategy to function optimally.18 
Brief BESTest. This condensed version of the Balance Evaluation Systems Test (BESTest) was 
developed to maximize results within limited clinic time.19 Minimally Clinically Important 
Difference (MCID) scores have not yet been established for this outcome measure, but the cut-
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off score to determine fall risk in the PD population is ≤ 11/2420 or 69%.21  
Biodex™ Balance SD (Shirley, New York) (BBSD). This system provides both quantitative 
and qualitative data regarding a subject’s ability to maintain their body’s center of mass within 
its base of support. 
Postural Stability. Greater amounts of body movement associated with an unstable 
posture produce a high stability index (SI); a low SI indicates little body movement and is 
associated with a more stable posture.22 Postural instability tends to occur in the later stages of 
PD, so maintaining it through strength and endurance training may lead to increased quality of 
life and fewer incidences of falls. 
Limits of Stability. Limits of stability (LOS) is tested on the BBSD via weight shifting to 
a visual target in eight different directions while maintaining balance on a platform via 
integration of sensory and motor control.23  The BIG™ protocol emphasizes weight shift, so it 
would be expected to see improvements on this measure following BIG™ training. 
Multi-directional Reach Test. Many activities of daily living require reaching in a variety of 
directions while safely maintaining balance.  Safety cut-off scores for community dwelling 
elderly persons are 8.38 inches (21.29cm) forward, 4.06 inches (10.31cm) backward, 6.12 inches 
(15.55cm) to the right, and 5.67 inches (14.40cm) to the left.24 
Functional Gait Assessment. This test measures safety with a variety of gait methods used in 
daily life.  Since patients with PD frequently have difficulty with backward stepping such as 
when opening doors or avoiding collisions in a crowd, this measure was included in the study. 
FGA cutoff scores to predict fall risk are ≤ 15/30 in Parkinson’s population21  and ≤ 22/30 in 
community-dwelling older adults (sensitivity 85%, specificity 86%).30 
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Instrumented Sit-to-Stand, Gait Initiation, and Gait Analysis. 
         Patients provided informed consent to be video recorded for gait quality analysis. 
Sit-to-Stand.  The surface EMG electrodes record muscle activation patterns showing 
force generated and muscle work. The process of transferring from sit to stand may be broken 
down into four kinematic phases, each requiring recruitment and coordination of distinct muscle 
groups which were measured via surface electrodes placed on the tibialis anterior and soleus 
muscles bilaterally: Flexion Momentum, Momentum Transfer, Extension, and Stabilization.18 
         Gait Initiation. To initiate gait, the patient first needs to weight shift onto the intended 
stance leg. EMG activity is a means of assessing this muscle activation for gait initiation.25  
        Gait. Short shuffling steps and increased double limb stance time are hallmarks of 
Parkinsonian gait. The GAITRite™ Gait Analysis System measures step length and cadence for 
comparison over time. Ideally, the focus on large amplitude movements through the BIG™ 
exercise program would result in improvement in these measures toward normalization. 
6 Minute Walk Test.  This test measures overall endurance with gait, as well as cardiac 
endurance. As the subjects progress through the four weeks of BIG™ training, their distance 
measured by 6MWT is expected to increase. The MCID for geriatric and stroke population is 50 
meters, or 164 feet.26 
Vital Signs.  Cardiovascular dysautonomia and autonomic nervous system dysfunction are 
common in PD, and roughly 50% of patients with advanced-stage PD have orthostatic 
hypotension.27 Heart rate, blood pressure, and digital pulse oximetry were monitored throughout 
all sessions during the eight-week program to ensure safety during exercise, as well as to assess 




         The data collection phase of study occurred over the span of 2 months which included 4 
days of baseline measurements 1 day per week, 4 weeks of 4 days of intervention with 1 day of 
testing.  Testing and interventions were performed at the same time of day across the study in an 
effort to standardize results across the participants’ medication cycle. 
          Initial evaluations included a signed informed consent, with a copy provided to the 
participant.  A brief medical history, physical, and neurological examination were completed 
with each participant. 
Baseline Testing. 1 day per week for 4 consecutive weeks, participants were tested in the 
outcome measures described above to determine a consistent baseline level of function as well as 
determine the rate of change due solely to test-retest participant learning rather than intervention. 
BIG intervention phase. A certified LSVT BIG™ therapist supervised trained examiners as 
they led participants through the program. Participants were scheduled for 4 consecutive days per 
week for 4 weeks, totaling 16 individualized sessions in one month.  60 minutes per session was 
allotted for performance of the intervention as well as for rest breaks, subjective reports, and 
review of daily homework. Each intervention session included all components of the LSVT 
BIG™ protocol as described on the LSVT site http://www.lsvtglobal.com/big-certification. 
During intervention phase. On the fifth day of each intervention week, data collection of all 
outcome measures took place to determine any physiological and functional changes that may 
have occurred. 
Data Analysis 
    Due to the single-subject design of the study, the most accurate depiction of significant 
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change required a change in the mean of two standard deviations.  See Results section for further 
details. 
RESULTS 
 Data for outcome measures are presented in figures. Figures contain baseline data points, 
during intervention data points, the mean, and two standard deviations. The mean in each figure 
is denoted by a dotted green line and significance level is represented with a dotted purple line. 
Notation of (SL; M) in results represents significance level (SL) determined from baseline mean 
± 2 standard deviations; maximum change (M) during intervention phase. 
         PD04 did not demonstrate any conclusive trend in performance of FTSTS. While PD05 
showed small improvement in performance of FTSTS (Fig. 1), he performed near age-related 
normal value throughout all data collection days31. Multi-directional reach results for PD04 were 
inconclusive for all directions (Fig. 2).  PD05 showed significant decrease in forward reaching 
but did demonstrate upward trend in reaching backward (SL 12.08 cm; M 21.10 cm), to the left 
(SL 18.98 cm; M 21.10 cm), and to the right (SL 18.40 cm; M 22.40 cm). PD04 did not 
demonstrate significant changes in the Brief BESTest. The results for PD05 of the Brief BESTest 
show consistent trend during baseline and intervention phases, with results remaining near the 
ceiling of the test which has a maximum score of 24 (Fig. 3). When testing postural stability on 
Biodex™ system, there were no significant changes noted for either subjects (Fig. 4A). Limits of 
stability, which was performed on Biodex™ system, showed an overall increase performance of 
PD04 (SL 39.6 points on Biodex™ balance index; M 48.0 points on Biodex™ balance index) 
during intervention period, as compared to baseline, with emphasis on weight shifting backward, 
to the right, and to the left. The results of PD05 also demonstrated an overall increase in 
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performance (SL 95.8 points on Biodex™ balance index; M 88 points on Biodex™ balance 
index) during the intervention period, when testing limits of stability on Biodex™ system. 
Despite this overall improvement in limits of stability (Fig. 4B), significant improvement was 
only found when testing limits of stability when weight shifting backwards (SL 91.5 points on 
Biodex™ balance index; M 96 points on Biodex™ balance index). 
         The results for PD04 demonstrated a significant increase in performance for the FGA (SL 
22.9 numerical total; M 26.0 numerical total) (Fig. 5). PD05 showed no significant change in 
FGA. The results in examining step length, step width, and velocity, showed no significant 
difference in either subject.  Both PD04 and PD05 showed no significant improvement in muscle 
activation as evidenced by EMG (data not shown), due to several limitations discussed later in 
this paper. Both subjects show a positive trend in improvement on the 6MWT (Fig. 6). PD04’s 
results were shown to trend into significance during the intervention period (SL 1264.5 ft; M 
1268.0 ft). The results of PD05 were significant throughout the last 3 data points during the 
intervention period (SL 1840 ft; M 1924 ft).  
Vital signs (Table 2) which include pre- and post-session blood pressure, heart rate, and 
oxygen saturation did not show any significant changes or trends.   
DISCUSSION 
 Participant PD05 showed a positive change on most tests, while PD04 did not.  PD04 
demonstrated measurable improvements in balance, especially the Limits of Stability and FGA, 
while PD05 met ceiling effect on FGA due to his high level of function.  The MDRT, Biodex™ 
Limits of Stability, and 6MWT were the most appropriate instruments to demonstrate change 
following the BIG™ protocol for PD05, whose symptoms more closely matched with the target 
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audience for BIG™. 
Improvements to balance measures were anticipated due to the BIG protocol’s emphasis 
on maximum effort in multidirectional weight shifts.  Both subjects reported one fall each within 
the past year, indicating that while falls are only a mild concern at present, fall prevention 
training will be important in the near future. FTSTS greater than 16 seconds indicates fall risk in 
the PD population17, so PD04 was considered a high risk for falls at baseline and PD05 was not.  
Also supporting this classification, PD04 began above the mean of 14.8 seconds for an 80-89 
year old community-dwelling adult31, again indicating an increased fall risk.  Though 
performance improved in significance during the intervention period, by both of the clinical 
standards she remained at high risk following the study.  Due to the fact that PD05’s baseline 
scores in FTSTS were near the mean normal for his age group31, the mild improvement seen is 
not considered clinically significant.  Another fall predictor previously studied in the PD 
community is the Brief BESTest, which places cutoff score for falls at < 11/24 points and mean 
normative score at 13.2.20 By this standard, PD04 would not be classified as a fall risk and scored 
above average for a person with PD.  This discrepancy in classification of risk demonstrates the 
importance of using various balance measures in the clinic.  The Brief BESTest is more accurate 
at identifying non-fallers (sensitivity 76%, specificity  84%)20 compared to the FTSTS 
(sensitivity 75%, specificity 68%)17, as a possible correlation to the variety of balance 
components it challenges.  However, due to the ceiling effect, it was not the most appropriate 
balance measure to detect change in active patients like PD05. 
MDRT and Biodex™ Limits of Stability test are parallel fall prediction methods that 
analyze multidirectional weight shifting, which is an activity emphasized in the BIG™ protocol.  
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Especially difficult for patients with PD is backward weight shift due to retropulsion, secondary 
to loss of postural stability.  As MDRT and Biodex™ LOS both demonstrate, more significance 
can be seen in backward weight-shifting scores for both subjects, especially PD05.  
The large-amplitude movements and maximum effort of the BIG™ exercise protocol 
were anticipated to translate into larger, faster, and more efficient muscle activation and 
subsequent translation into functional movements such as sit-to-stand and gait. Despite EMG 
data showing inconclusive results, video footage of instrumented gait demonstrated qualitative 
clinical improvements in gait over the course of the intervention phase. This was especially 
noted for timing of weight shift and dorsiflexion during swing phase of gait. This may have 
clinical and functional applications in efficiency of gait and reduced fall risk. 
On the 6MWT, PD04 showed a trend toward clinical significance in distance walked 
throughout entire intervention phase and passed significance on the last data point, though her 
progress did not meet the established MCID of 164ft for the geriatric population which would 
demonstrate improvement in gait speed.26 PD04 exhibited kyphotic posture with possible 
stabilization via co-contraction to decrease the impact of tremors, which may relate to less 
improvement in distance walked. PD05’s results surpassed both significance of two-standard 
deviations and clinical significance during intervention period and stabilized at approximately 
the same level on the last 3 data collection days, pointing to improvement in efficiency with gait. 
This was seen in PD05’s increased trunk rotation, increased rate and amplitude of arm swing, 
longer step length, and increased cadence during 6MWT throughout the intervention phase. 
Prior studies demonstrate that resistance training above 50% of heart rate reserve may 
lead to positive cardiac adaptation in endurance and efficiency11, so the researchers hypothesized 
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that the BIG’s™ emphasis on maximum effort may have similar effects.  As previously 
mentioned, roughly 50% of patients with advanced-stage PD have orthostatic hypotension, 
which can also be worsened by various classes of PD drugs including levodopa carbidopa.27  One 
study found an oral dose of 200 mg levodopa/50 mg benserazide to cause decrease in mean 
arterial pressure, cardiac stroke volume, and measures of cardiac contractility, which may lead to 
decreased cardiovascular performance.28 In a systematic review, one study found lower systolic 
BP during exercise in subjects with PD, but results were not significant.29  The results of our 
monitoring of subjects’ vitals also did not show significant change with exercise, as both 
patients’ medications included substances known to decrease cardiovascular response. 
There were multiple limitations in regards to this study. Due to time constraints, this 
study was narrowed to an A-B design as opposed to an A-B-A design which monitors effect of 
BIG™ protocol past intervention phase. Therefore, it is impossible to determine how long 
positive effects lasted after the intervention phase concluded and if the subjects continued 
performing their home exercise program like the BIG™ protocol prescribes. Consequently, it 
cannot be concluded the benefits the subjects received from the BIG™ protocol continued past 
the conclusion of this study. 
         The limited number of people with PD willing to participate in four weeks of baseline 
testing followed by a four week exercise program lead to a convenience sampling of subjects 
who were not necessarily ideal candidates for the BIG™ protocol. PD04 was able to participate 
in all activities; however, upper extremity tremor often impeded performance during testing. 
Intensity of PD04’s tremor varied on each testing day, resulting in variance of performance. 
Moreover, due to the small sample size, firm conclusions cannot be made from the results of the 
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study. With a bigger sample size of subjects, who exclusively have bradykinesia and rigidity, 
correlation of cause and effect would be more evident and definitive conclusions could be made 
with increased certainty.   
Sensitivity of equipment was a significant factor affecting multiple outcome measures. 
Significant upper extremity tremor was a common sign of PD04 which made it difficult to attain 
accurate vitals. In addition, PD04 had limited circulation to the fingers, making pulse oximetry 
difficult and limiting its reliability. Also, despite PD05 being a more ideal candidate, slight 
tremor in multiple muscles of the lower leg caused interference when measuring muscle 
activation with EMG. 
Future research should focus on the effect of balance and gait of people with PD who 
only present with bradykinesia and rigidity. This will allow for more accurate results from the 
subjects. Furthermore, the power of the results would also benefit from an increase in sample 
size. Researchers could then generalize conclusions to the PD population primarily affected by 
bradykinesia and rigidity. Lastly, focus should be placed on determining how long the effects last 
for people with PD who undergo the BIG™ protocol. 
 In conclusion, both subjects demonstrated significant improvement on multiple objective 
measures of performance following four weeks of LSVT BIG™ exercise training. PD05 proved 
to be the more appropriate candidate for the LSVT BIG™ due to his primary issues of 
bradykinesia and rigidity. However, due to limitations of study, conclusions cannot be 
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Table 1. Subject Data 
Subject PD04 PD05 
Sex F M 
Age 81 63 
Length of PD Diagnosis 3.5 years 
(20 years treated for tremor, 
which is present at rest and 
worsens with excitement or 
anxiety) 
0.5 years 
(1 yr ago first signs) 
Primary Symptoms 








Secondary Symptoms Right thigh dyskinesia,  
Difficulty swallowing 
Stiffness in back and both 
hips after prolonged sitting, 
Dry eye, 
Double vision with fatigue, 
Difficulty swallowing, 
Vocal fatigue and decreased 
volume, 
Acting out nightmares, 
Pill-rolling tremor 
PD Medication  
● drug class 
Ropinirole  
● dopamine agonist 
Propranolol 
● beta blocker 
Carbidopa 
● DOPA decarboxylase 
inhibitor 
Carbidopa/Levodopa 
● dopamine precursor 
Azilect 
● Monoamine oxidase 
inhibitor [MAOI] 
Vitamin D 





Table 2. Vital Sign Raw Data 



















Intervention Systolic Diastolic Sys. Dia. Sys. Dia. Sys. Dia. 
B1 110 75 118 70 140 80 142 82 
B2 125 75 138 78 138 85 142 82 
B3 121 58 147 65 136 71 131 75 
B4 126 75 146 67 130 76 142 73 
I1 124 74 144 63 139 75 151 81 
I2 141 68 128 58 160 82 156 78 
I3 120 58 132 68 111 67 133 77 
I4 114 56 126 63 119 68 137 75 
 mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg 
 











B1 55 92 48 51 
B2 59 57 50 58 
B3 60 54 58 64 
B4 58 62 58 55 
I1 57 63 49 54 
I2 65 62 58 70 
I3 60 54 61 70 
I4 61 58 54 72 

















B1 94  97 98 
B2 95 92 95 98 
B3 99 99 98 99 
B4 90 100 97 98 
I1 97 83 99 99 
I2 97 99 99 99 
I3 98 97 97 98 
I4 98 97 97 98 







The figures showing the data of the study have a consistent format. Unless denoted 
otherwise in the legend, the initial 4 data points represent baseline period and are noted with blue 
marker points which are connected with a blue line. The last 4 data points, which were taken 
during BIG™ intervention, are noted in red and connected with red line. The horizontal green 
dotted line represents the mean of the data points during the baseline period. The horizontal 
purple dotted line represents two standard deviations from the horizontal green dotted line and 
can be considered significant. The purple dotted line will be above or below the green line based 



















Five Times Sit to Stand 
A decrease in time demonstrates improvement in performance with the FTSTS. PD04’s 
performance was variable during baseline phase and during intervention phase. PD05’s 





























Multidirectional Reach Test  
         PD04: Overall the performance of PD04 during the MDRT was not constant during the 
baseline period. During the intervention phase, the distance reached to the right and left 
stabilized and did not change significantly from the baseline mean. 
         PD05: In contrast to the performance of PD04, PD05 was much more consistent in reach 
distances during the baseline phase. During the intervention, PD05 exhibited a significant loss of 
forward reach. However, the subject’s performance in the other directions increased over the 4 
weeks of intervention.  Backward reach was found to cross significance threshold in data 
collection day 7 and continued to trend upward on data collection day 8. Right and left reach 











PD04 demonstrated trend toward significance during intervention period, however her 
results did not cross significant threshold at any time. PD05 initially demonstrated a positive 
trend toward significance but results did not vary throughout the last three data points during the 














A. Postural Stability 
 
Biodex™ Testing 
This measure is used to determine static standing balance utilizing the Biodex™ 
balance system. A lower score on the balance index indicates improved balance while standing 
on a static surface. PD04 and PD05 demonstrated little change during the intervention period as 
compared to the mean of the baseline period. Also, no trends in a positive or negative direction 
can be noted.  
B.  Limits of Stability 
 
Biodex™ Testing 
This measure is utilized to determine standing balance during weight shifts utilizing the 
Biodex™ balance system. A higher score signifies being able to maintain balance while weight 
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shifting in a given direction. All results for PD04 were found to be significant during the 
intervention period. The results for PD05 during the intervention period were not found to be 








Functional Gait Assessment 
PD04 demonstrated a trend toward significance in the intervention period compared to 
baseline, and results were considered significant in the last two data points. PD05 demonstrated a 
decline in results without any perceivable trend. Due to ceiling effect, it would be impossible for 
PD05 to reach significant results since the FGA has a top score of 30 points and significance 





Six Minute Walk Test 
         The results for PD04 showed a trend toward significance throughout the entire 
intervention phase and passed significance on the last data point. PD05’s results surpassed 
significance during intervention period and stabilized at approximately the same level on the last 














Appendix A – Outcome Measure Instructions 
Five Times Sit-to-Stand (FTSTS).  Participant was seated in an armless chair with a seat 
approximately 43 cm from the ground.  Participant was instructed to cross their arms over their 
chest and sit with their back against the back of the chair.  An investigator demonstrated the 
correct technique of task performance, including coming to a full stand with upright trunk and 
knees extended followed by sitting down with back making contact with chair back.   Timing of 
the participant began when an investigator said 'go' and stopped when the participant's back 
reached the chair back after the fifth stand.17 
6-Minute Walk Test (6MWT).  One hundred feet of level tile floor was marked off by a cone at 
each end.  Participants were given the following instructions:  "When I say 'go', I want you to 
walk around the two cones.  Keep walking until I say 'stop' or until you are too tired to go any 
further.  If you need to rest, you can stop until you are ready to go again.  I am interested in how 
far you can walk.  You can begin when I say 'go.'"  The following encouragements were 
provided: 
         1. After one minute "You are doing well.  You have 5 minutes to go."  
         2.  At two minutes "Keep up the good work.  You have 4 minutes to go." 
         3. At 4 minutes "Keep up the good work.  You have two minutes left." 
         4. At 5 minutes "You are doing well.  You have only one minute to go."  
Fifteen seconds prior to completion the participants were informed that time would stop shortly, 
and the test was stopped at six minutes.  Total distance walked was measured.  Throughout the 
test, notation was made about any rests and walking difficulties. 
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Functional Gait Assessment (FGA). The FGA consists of ten activities following standardized 
instructions and scoring by Wrisley and Kumar30.  The ten activities are:  Gait on a level surface, 
Change in gait speed, Gait with horizontal head turns, Gait with vertical head turns, Gait and 
pivot turns, Step over obstacle, Gait with narrow base of support, Gait with eyes closed, 
Ambulating backwards, and Steps.  The standard distance is 20 feet for all activities except gait 
with a narrow base of support (12 feet) and stairs. 
Multi-Directional Reach Test (MDRT).  This test measures limits of stability in four directions 
was a clinical measure that approximates the Limits of Stability Test on the Biodex™ Balance 
SD described below.  The participant stood with feet shoulder width apart and one arm raised to 
90 degrees of shoulder flexion with the hand in a fist adjacent to (but not touching) the 
chalkboard.  The body was aligned perpendicular to the chalkboard and the arm parallel.   The 
investigator placed a mark on the chalkboard at the level of the third metacarpal joint, using a 
triangle ruler for accuracy.  The participant was instructed to reach as far forward as he/she could 
while maintaining his/her balance and not moving his/her feet or taking a step.  The investigator 
then made a second mark at the level of the third metacarpal’s new position.  Next the participant 
was asked to lean backwards as far as he/she could without losing balance or moving feet, and a 
third mark will be made at metacarpal level.  The participant was then instructed to turn with 
his/her back parallel to the chalkboard and raise the right arm to the side at shoulder level.  The 
investigator made a mark as described above.  The participant was asked to reach to the right as 
far as possible without moving feet or taking a step. The investigator made another mark, and the 
process was then repeated with the left arm. The investigator recorded the distances reached and 
the preferred arm for forward and backward reach. 
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Brief BESTest. This test consists of 6 varying components of balance:  Biomechanical 
constraints, Stability limits, Transitions-anticipatory postural adjustments, Reactive postural 
response, Sensory orientation, and Stability in gait.  The standardized instructions and scoring by 
Padgett et al were used.19 
Biodex™ Balance SD. This equipment system has a platform with sensors underneath to detect 
the changes in a person's center of gravity.  The platform was stabilized (immobile) for the two 
tests.  A monitor providing visual cues during the test was placed at eye level.  Participants were 
permitted to use the hand rails when transitioning on or off the platform and at any time they felt 
unsteady.  Prior to the testing, the participant's feet were placed in the standardized position 
(shoulder width apart with the anterior ankle centered anteriorly/posteriorly on the frontal axis of 
the platform). The first time on the platform, the participant’s feet placement was traced onto a 
sheet of paper labelled with the participant’s identification code to ensure consistency for all data 
collection sessions on the Balance SD. 
a)  Postural stability. This test examined the participant's ability to maintain center of balance.  
The participant was instructed to watch the monitor and try to keep the dot indicating center of 
balance aligned in the cross-hairs. The dot moved in response to the participant's postural sway 
upon the platform. The Balance SD recorded the amount of sway in all directions to compare the 
amount of sway to norms by age of participant. 
b)  Limits of Stability. This test challenged the participant's ability to move and control his/her 
center of gravity, a measure of dynamic balance.  The participant aligned their center of mass by 
moving shifting on the platform to align the cursor on the screen with the center dot.  One of 
  
35 
eight outer dots blinked, and the participant was instructed to move the cursor to the blinking dot 
by shifting his/her weight in that direction.   
Instrumented Sit-to-stand, Gait initiation, and Gait 
Common equipment for all three activities was electromyography (EMG) surface electrodes 
superficial to the gastrocnemius and anterior tibialis muscles bilaterally.  Signals were sent to the 
computer via telemetry, and videos were taken during testing to enhance analysis.  Once gait was 
initiated, the participant continued walking forward across the GAITRite™ mat.  This rubberized 
surface had been embedded pressure sensors to track the interaction of the feet with the surface 
to provide information such as step length, step width, and gait speed. 
a)  Sit-to-stand. The participant began the test seated in the the standard chair used in the FTSTS 
and was given the instructions “Ready. Set. Stand.” 
b)  Gait Initiation. From the standing position, the participant was given the instructions “Ready. 
Set. Walk.”   
c)  Gait from Seated Position. From the seated position in the standard chair, the participant was 
given the instructions “Ready. Set. Stand and walk.” 
Cardiopulmonary.  During each intervention day, the participant was asked to wear a Polaris 
heart rate monitor when performing BIG™ exercises to determine if their heart rate was within 
the training window for cardiac conditioning.  Beginning and ending heart rate, as well as blood 
pressure via Dynamap or manual sphygmomanometer and oxygen saturation via fingertip pulse 
oximeter were recorded each intervention day.  These vital signs were also monitored and 
recorded at various points throughout each exercise session to ensure subject safety. 
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